Laboratory tests Published · updated

Western blot and serological testing for Borrelia burgdorferi in the diagnosis of Lyme disease

This article aims to explain the role of testing for antibodies to Borrelia burgdorferi in the diagnosis of Lyme disease.

Diagnosing Lyme disease

Lyme disease is caused by bacteria of the Borrelia burgdorferi sensu lato group. The group includes several species, of which B. burgdorferi sensu stricto (B. burgdorferi) is typical of North America, while B. burgdorferi, Borrelia garinii and Borrelia afzelii are typical of Europe and Asia. Lyme disease is diagnosed on the basis of a clinical examination and laboratory testing. Two types of test are used in laboratory testing: initial serological tests and the Western blot.

Why are antibodies to Borrelia burgdorferi measured?

When the body is exposed to the bacterium Borrelia burgdorferi, the immune system produces antibodies – proteins that bind to the bacterium and try to neutralise it. Testing for these antibodies is used to confirm a diagnosis of Lyme disease.

When are initial screening tests for Lyme disease used?

Testing starts with measuring IgM and IgG class antibodies to Borrelia species. For antibodies to form and be detected, a certain amount of time has to pass after the infection, so that the antibodies reach a concentration high enough to be measured. IgM antibodies take 3 to 6 weeks to reach their highest concentration and in some cases can remain in the blood for years. IgG class antibodies appear 2–3 weeks after infection and remain for years after the symptoms have gone.

The result of antibody screening tests can be negative, borderline or positive. If an acute infection is suspected and the serological test result is negative, a second sample can be tested 2–3 weeks later.

When is the Western blot for Borrelia burgdorferi used?

The Western blot helps to distinguish false-positive results from true cases of Lyme disease. It is considered more specific than the initial screening tests and provides additional evidence to support the diagnosis when clinical symptoms are present.

A borderline or positive screening result should therefore be confirmed by Western blot testing of the same or another sample. Only when the Western blot confirms the presence of antibodies to the bacterium is the overall result considered positive.

Limitations of serological testing

The timing of the tests is very important, because it takes time for antibodies to form. A test done too early may give a negative result even though the infection is present.

Antibiotics that have been taken can also suppress the immune response, which can lead to a negative result.
Because of cross-reactivity, serological test results can be false positives, which is why they must be checked by Western blot testing.

Limitations of Western blot testing
It is important to note that Western blot testing also has some limitations:

  • timing of the test – it can take several weeks for antibodies to develop after the initial infection, which can lead to false-negative results in the early stages of Lyme disease;
  • interpreting the results – interpreting Western blot results requires expertise, as test results can vary depending on the laboratory and the interpretation criteria used.

The Western blot and serological antibody testing for Borrelia play an important role in confirming a diagnosis of Lyme disease. By detecting the specific antibodies the body produces in response to the bacterium, these tests give doctors important information. However, when interpreting the results of these tests, it is important to take into account the clinical symptoms, the patient’s medical history and the characteristics of the tests themselves.

These tests should not be used to screen the general population, but only in people who have been in places where they could have come into contact with ticks, have been exposed to tick bites and are suspected of having Lyme disease on the basis of their symptoms. Depending on where the patient has been, there are tests for antibodies to the Borrelia species typical of North America, Europe and Asia.

If you suspect Lyme disease, talk to your doctor, who will explain how the diagnosis is made and, if the infection is confirmed, recommend appropriate treatment.

Tests

Back to top